Dorian Bevec

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (February 2010) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. Find sources: "Dorian Bevec" – news · newspapers · books · scholar · JSTOR (February 2010) (Learn how and when to remove this message) (Learn how and when to remove this message)

Dorian Bevec is a German molecular biologist, Chief Scientific Officer and co-founder at Mondobiotech.^[1] He was born on May 21, 1957, in Zagreb, FPR Yugoslavia.

• 1980 B.Sc. in general biology, Justus-Liebig-University,^[2] Giessen, Germany
• 1983 M.Sc. in biology, Justus-Liebig-University, Giessen, Germany
• 1984 Visiting Scientist at the Basel Institute for Immunology, Lab. Michael Steinmetz, Basel, Switzerland
• 1983–1985 Scientist at the Institute of Virology, Justus-Liebig-University, Giessen, Germany
• 1985–1988 Scientist at the Laboratory for Molecular Biology of the Ludwig Maximilian University of Munich, Germany
• 1988–1989 Post-doctoral Research Fellow at Sandoz Research Institute, Vienna, Austria
• 1989 Ph.D. in biology, Ludwig Maximilians-University, Munich, Germany

From 1989 to 1990 he was laboratory head at the Department of Immunopharmacology at Sandoz Research Institute, Vienna, Austria, and, after a year as visiting scientist at the Memorial Sloan-Kettering Cancer Center, Laboratory Head, Department of Anti-Retroviral Therapy at Sandoz. In 1996, he became Head of the Molecular Biology Group there. In 1997 he received the Dr. habil. in human virology from the University of Vienna. He then joined Novartis Research Institute as Programme Team Head, Department of Immunology, and, in 1999, became Group Leader and Vice President, Research & Head of Platform Technologies at Axxima Pharmaceuticals AG, Martinsried, Germany; in 2001 he co-founded Mondobiotech Group, Stans, Switzerland, where he took the position of Chief Scientific Officer.

• Mondobiotech
• Justus-Liebig-University Giessen
• Ludwig-Maximilians-University Munich Archived 2011-08-10 at the Wayback Machine
• University of Vienna